Trump Crushes Biotech, Gives Investors A Gift Buying Opportunity

Soon to be President Donald Trump gave investors a gift. The smart ones could not refuse. The Donald trashed biotech in his press conference causing a massive sell-off. Select biotech stocks that took a beaten, hit major support levels and offered investors an extremely cheap valuation buying level. In my opinion, this is the case with Endo International plc (NASDAQ:ENDP). The stock flushed into a major double bottom support level at $13.75. Based on valuation metrics, this is down right cheap. In addition, this tough talk on biotech drug pricing is nothing new. It has been going on for well over a year. In my opinion, there is little downside left as everything has been factored in. I believe this was a gift buying opportunity on many biotechnology stocks like Endo International plc (NASDAQ:ENDP). Others that are interesting are Gildead Sciences, Valeant Pharma and Teva Pharma.

I was trained as a psychologist, then I applied what I knew to stock trading. Stocks are representing emotion of those who buy/sell them. I post all of my trades on Insert-tag-hereVerifiedInvesting.com where they are confirmed for legitamacy by their independent verification system. I've been trading since the 90s.